TP53 and carcinoma: The DEGs with reduced expression were primarily enriched in PI3K-Akt, TNF and p53 signaling pathways, protein digestion and absorption, proteoglycans in carcinoma, small cell lung carcinoma, tryptophan metabolism, and bladder carcinoma (Figure 2(d)).